Faster access than browser!
5 relations: Fast track (FDA), Food and Drug Administration, Liberty Fund, Orphan drug, Surrogate endpoint.
Fast track (FDA)
Fast Track is a designation by the United States Food and Drug Administration (FDA) of an investigational drug for expedited review to facilitate development of drugs which treat a serious or life-threatening condition and fill an unmet medical need.
New!!: Accelerated approval (FDA) and Fast track (FDA) · See more »
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
New!!: Accelerated approval (FDA) and Food and Drug Administration · See more »
Liberty Fund
Liberty Fund, Inc. is a nonprofit foundation headquartered in Indianapolis, Indiana which promulgates the libertarian views of its founder, Pierre F. Goodrich through publishing, conferences, and educational resources.
New!!: Accelerated approval (FDA) and Liberty Fund · See more »
Orphan drug
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
New!!: Accelerated approval (FDA) and Orphan drug · See more »
Surrogate endpoint
In clinical trials, a surrogate endpoint (or marker) is a measure of effect of a specific treatment that may correlate with a real clinical endpoint but does not necessarily have a guaranteed relationship.
New!!: Accelerated approval (FDA) and Surrogate endpoint · See more »
Redirects here:
Accelerated Approval, Accelerated Approval (FDA), Accelerated approval, FDA Accelerated Approval, FDA Accelerated Approval Program.
References
[1] https://en.wikipedia.org/wiki/Accelerated_approval_(FDA)
